Thymosin Alpha-1: What It Is, What the Research Says, and What You Need to Know
An immunomodulating peptide approved in 40+ countries for immune support
Last updated: May 1, 2026
Educational purposes only. The information on this page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Research peptides are not FDA-approved for human therapeutic use unless explicitly stated. Always consult a licensed healthcare provider before using any compound.
What Is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1) is a naturally occurring peptide produced by the thymus gland — the organ responsible for T-cell maturation. It was first isolated by Dr. Allan Goldstein in the 1970s.
Unlike most peptides on this list, Tα1 has extensive clinical trial data and regulatory approval in over 40 countries. It is sold as Zadaxin (SciClone Pharmaceuticals) for chronic hepatitis B and C treatment and immune deficiency.
During COVID-19, thymosin alpha-1 was used in China as part of treatment protocols with reported benefits in severe cases.
What Does the Research Say?
- Multiple RCTs support Tα1's efficacy in improving immune response in chronic hepatitis B and C.
- Studies show restoration of T-cell function in elderly and immunocompromised patients.
- Cancer research shows improved outcomes when combined with conventional chemotherapy.
- Studies in COVID-19 patients suggest reduced severity and mortality.
- The IRCT trial showed improved survival in septic shock patients.
Research context: Animal studies showing positive effects do not guarantee the same results in humans. Human evidence strength varies significantly by peptide — see the Quick Stats sidebar for details.
Common Use Cases in Research
These reflect how researchers and research communities discuss this compound — not therapeutic recommendations.
- Immune system restoration
- Chronic viral infection treatment (hepatitis B/C)
- Cancer immunotherapy adjunct
- General immune enhancement
How It Works (Mechanism of Action)
Enhances T-cell development and differentiation, upregulates MHC class I expression, promotes cytokine production (IL-2, INF-γ), and restores immune function in immunocompromised patients.
Reported Benefits & Risks
Reported Benefits
Reported Risks
What People Ask
Is Thymosin Alpha-1 FDA-approved?
Not in the US. It is FDA-designated as an Orphan Drug and has been studied in US trials but is not currently FDA-approved. It is approved as Zadaxin in over 40 other countries for hepatitis and immune conditions.
Legal & Regulatory Status
Approved internationally (Zadaxin). Research Only in US.
Approved in 40+ countries as Zadaxin. Not FDA-approved in the US — available as research chemical.
Commonly Stacked With
Research Suppliers
Affiliate link below — we may earn a commission if you purchase. This does not influence our research coverage.
View Thymosin Alpha-1 Research Suppliers (affiliate link)